|search over 1,000 Venture Capital related sites|
|1.||Kaiser Permanente (100%):|
Introduction to Kaiser Permanente and Venturing Since 1945, Kaiser Permanente has distinguished itself as one of the nation's largest and most comprehensive health care delivery systems. With operations in nine states and the District of Columbia, Kaiser Permanente now serves 8.4 million members. Ou...
|2.||Kaiser Permanente (99%):|
Our Venture Fund and Investment Profile Kaiser Permanente operates a Venture Fund and is actively seeking investments in which it can financially and strategically participate. As a national, vertically-integrated healthcare organization, Kaiser Permanente presents a broad range of alliance opportun...
|3.||Kaiser Permanente (75%):|
BACK CHRIS GRANT Director 510-625-4009 Chris.M.Grant@kp.org Chris Grant is a Vice President in Kaiser Permanente's venture capital and corporate development group. In this role, Chris is responsible for the creation, oversight and management of several national business initiatives and is central to...
|4.||Kaiser Permanente (74%):|
BACK CHRIS STENZEL Senior Vice President 510-625-4001 Chris.Stenzel@kp.org Chris Stenzel is the Senior Vice President of Kaiser Permanente's venture capital and corporate development group. He oversees Kaiser Permanente's venture investment strategy, which is designed to support the company's health...
|5.||Kaiser Permanente (71%):|
BACK ROBERT WARD Practice Leader 510-625-4004 Bob.Ward@kp.org Bob joined Kaiser Permanente's venture development group in 1997. He is responsible for managing the pipeline of new venture prospects as well as leading investment evaluations and financing decisions. In 2002, he was instrumental in esta...
|6.||Kaiser Permanente (57%):|
Testimonials Assets Investment capital Association with the nation's largest integrated delivery system Strong, nationally recognized brand name and image Substantial purchasing power State of the art medical facilities, including 31 medical centers (hospitals), 435 medical offices, and both clinica...
|7.||Kaiser Permanente (36%):|
Please direct your inquiries to: CHRIS STENZEL | BIO Senior Vice President 510-625-4001 Chris.Stenzel@kp.org CHRIS GRANT | BIO Director 510-625-4009 Chris.M.Grant@kp.org ROBERT WARD | BIO Practice Leader 510-625-4004 Bob.Ward@kp.org DAVID SCHULTE| BIO Senior Venture Manager 510-625-4110 David.Schult...
|8.||Kaiser Permanente (30%):|
Portfolio Companies KP Ventures has invested in more than 20 companies in three healthcare sectors: Device, Service and Information Technology . Gynecologic Device www.adiana.com Adiana is developing products for non-surgical, office-based gynecological procedures. The lead product is a minimally in...
|9.||Conning Capital Partners: Press Release (23%):|
Press Release May 7, 2002 Cogent Healthcare, Inc. Receives $15 Million In New Funding Cogent Model Improves Patient Care for Less Cost, Makes Better Use of Scarce Health Care Resources Laguna Hills, Calif., May 7, 2002 - Cogent Healthcare, Inc., one of the nation's leading providers of inpatient phy...
|10.||Industry Ventures (21%):|
\ < back to news index Workstream Inc. To Acquire PureCarbon Inc. PureCarbon enables Workstream to provide a fully integrated end-to-end corporate career site and hiring management solution to the Fortune 2000 Ottawa, CANADA - June 25, 2002 - Workstream Inc. (NASDAQ: WSTM) - a leading prov...
|11.||Chrysalis Ventures (19%):|
< Back For Immediate Release Contact: Eileen Faas, Marketing HealthMedia, Inc. 734-623-5474 email@example.com Tim Petersen, Managing Partner Arboretum Ventures 734-998-3688 Koleman Karleski, Principal Chrysalis Ventures 502-583-7644 HealthMedia, Inc. Raises $2 Million of Growth Capital Arbore...
|12.||CHL Medical Partners (17%):|
recent news 2004 news 2003 news chl medical partners links to portfolio company news Threshold Pharmaceuticals Initiates Phase 1/2 Trial Evaluating Glufosfamide As First-Line Pancreatic Cancer Therapy South San Francisco, CA December 20, 2004 Threshold Pharmaceuticals, Inc. (www.thresholdpharm.com) ...
|13.||GreenHills Ventures (16%):|
Investors: Login | Businesses: Submit Plan GreenHills Ventures, LLC., combines extensive advisory experience with strategic initiatives. We focus on providing strong fundamentals to facilitate sound business execution. GreenHills Ventures, LLC., has developed an extensive network of Fortune 1000 co...
|14.||EARLYBIRD | Venture Capital (16%):|
Date Portfolio Exit September 2005 Esmertec AG www.esmertec.com IPO (SWX: ESMN) September 2005 Interhyp AG www.interhyp.de IPO (Prime Standard Frankfurt Exchange: IYP) April 2004 Element 5 AG www.element5.com Trade Sale to Digital River, Inc. (NASDAQ: DRIV) September 2003 kiwilogic.com AG www.kiwil...
|15.||EARLYBIRD | Venture Capital (16%):|
Datum Portfolio Exit September 2005 Esmertec AG www.esmertec.com IPO (SWX: ESMN) September 2005 Interhyp AG www.interhyp.de IPO (Prime Standard der Frankfurter B rse: IYP) April 2004 Element 5 AG www.element5.com Verkauf an Digital River, Inc. (NASDAQ: DRIV) September 2003 kiwilogic.com AG www.kiwi...
|16.||Buerk Dale Victor, LLC - Investment Philosophy (15%):|
(206) 621-7272 Neil joined BDV to serve as Strategic Director in 2002. He also is President of McReynolds Associates, Inc., a corporate governance consulting firm that advises CEOs and boards of corporations, nonprofits and trade associations on how to improve their effectiveness. He also ser...
|17.||Marshall Erdman & Associates Ownership Transition Packet - Timeline (15%):|
Our Work Careers About Us Contact Us Request Info Media Inquiries Home Media Resources Marshall Erdman & Associates Ownership Transition Historical Timeline 2004 Marshall Erdman & Associates acquired by Baird Capital Partners and Lubar & Co. 2003 ME&A achieves revenue of $206 million...
| Log-in | Links | Contact | ENG Onze portefeuille Historische exits Persberichten Archief Zoek nieuws Inschrijven LS < Team Hands-by Portfolio Management GIMV Life Sciences Team 65 jaar expertise in Life Sciences en Venture Capital GIMV Life Sciences heeft 3 specialisten die haar dossier...
|19.||HRCo Investors (14%):|
Our investors have included AXA Secondary Fund Bank of America Den Danske Bank Family Offices & Individuals Farm Bureau Life Insurance Company GE Capital Commercial Finance General Trust Company LTD. Henry J. Kaiser Family Foundation Massachusetts Mutual Life Insurance Company Minnesota Mutual L...
|20.||Granite Ventures, LLC (14%):|
< back to news index February 2, 2004 Verity Announces Agreement to Acquire Cardiff Software Intellectual Capital Management Leader to Extend Capabilities to Content Capture, e-forms and Business Process Automation San Diego, CA - February 2, 2004 - Verity Inc. (NASDAQ: VRTY), a leading provider ...